Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick Y Muller

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Current Oncology Reports|April 30, 2026
Clinical Development of Novel-Novel Multi-Company Combination Therapies in OncologyPatrick Y Muller, Johannes Eisinger, Pakeeza Sayyed, et al.
Drug Discovery Today|May 4, 2016
Secondary pharmacology: screening and interpretation of off-target activities - focus on translationSteven Whitebread, Berengere Dumotier, Duncan Armstrong, et al.
Anticancer Research|August 15, 2002
Expression of COX-2 and Wnt pathway genes in adenomas of familial adenomatous polyposis patients treated with meloxicamZuzana Dobbie, Patrick Y Muller, Karl Heinimann, et al.
Atherosclerosis|July 18, 2002
Sterol-regulatory element-binding protein (SREBP)-2 contributes to polygenic hypercholesterolaemiaAndré R Miserez, Patrick Y Muller, Luca Barella, et al.
Drug Discovery Today|September 24, 2018
Safety differentiation: emerging competitive edge in drug developmentMarianne Uteng, Laszlo Urban, Dominique Brees, et al.
Mabs|April 28, 2010
Safety and immunotoxicity assessment of immunomodulatory monoclonal antibodiesFrank R Brennan, Laura Dill Morton, Sebastian Spindeldreher, et al.
Anticancer Research|January 18, 2003
Overexpression of Wnt target genes in adenomas of familial adenomatous polyposis patientsDaniel D'Orazio, Patrick Y Muller, Karl Heinimann, et al.
Biochimica Et Biophysica Acta|May 26, 2004
Identification of hepatic molecular mechanisms of action of alpha-tocopherol using global gene expression profile analysis in ratsLuca Barella, Patrick Y Muller, Manfred Schlachter, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Current Oncology Reports|April 30, 2026
Clinical Development of Novel-Novel Multi-Company Combination Therapies in OncologyPatrick Y Muller, Johannes Eisinger, Pakeeza Sayyed, et al.
Drug Discovery Today|May 4, 2016
Secondary pharmacology: screening and interpretation of off-target activities - focus on translationSteven Whitebread, Berengere Dumotier, Duncan Armstrong, et al.
Anticancer Research|August 15, 2002
Expression of COX-2 and Wnt pathway genes in adenomas of familial adenomatous polyposis patients treated with meloxicamZuzana Dobbie, Patrick Y Muller, Karl Heinimann, et al.
Atherosclerosis|July 18, 2002
Sterol-regulatory element-binding protein (SREBP)-2 contributes to polygenic hypercholesterolaemiaAndré R Miserez, Patrick Y Muller, Luca Barella, et al.
Drug Discovery Today|September 24, 2018
Safety differentiation: emerging competitive edge in drug developmentMarianne Uteng, Laszlo Urban, Dominique Brees, et al.
Mabs|April 28, 2010
Safety and immunotoxicity assessment of immunomodulatory monoclonal antibodiesFrank R Brennan, Laura Dill Morton, Sebastian Spindeldreher, et al.
Anticancer Research|January 18, 2003
Overexpression of Wnt target genes in adenomas of familial adenomatous polyposis patientsDaniel D'Orazio, Patrick Y Muller, Karl Heinimann, et al.
Biochimica Et Biophysica Acta|May 26, 2004
Identification of hepatic molecular mechanisms of action of alpha-tocopherol using global gene expression profile analysis in ratsLuca Barella, Patrick Y Muller, Manfred Schlachter, et al.
Pageof 2